We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Ritu Swali

Ritu Swali MD

Post-Graduate Clinical Research Fellow, Center for Clinical Studies, Houston, Texas

Recent Contributions to PracticeUpdate:

  1. Intralesional Cidofovir for Treatment of Recalcitrant Warts in Both Immunocompetent and Immunocompromised Patients
  2. Association Between Fetal Safety Outcomes and Exposure to Local Podophyllotoxin During Pregnancy
  3. Recalcitrant Cutaneous Warts Treated With Quadrivalent HPV Vaccine
  4. Intralesional vs Intramuscular Bivalent HPV Vaccine in the Treatment of Recalcitrant Common Warts

Most Read This Week

Recently Updated